The global blood collection market is witnessing considerable
growth due to increasing geriatric population, increasing number of accidental
cases and growing surgical procedures. Moreover, growing prevalence of chronic
diseases including cancer, cardiovascular disease, infectious diseases,
autoimmune diseases, diabetes mellitus, and infectious diseases is supporting
the growth of the market. Based on product type, the blood collection needle
and syringe segment lead the market. The increasing demand of needle and
syringe for blood collection across the globe, owing to their easy availability
and ease of use, is driving the growth of this segment. In addition, rising
initiatives undertaken by government associations to boost awareness about
blood donations and advanced features of blood collection products are also
supporting to the growth of this market.
Request for Report Sample at: https://www.psmarketresearch.com/market-analysis/blood-collection-market/report-sample
The use of RFID technology in blood banks and transfusion medicine
has the potential to improve operational efficiency. It helps in providing
patient safety at point of care by automatically identifying, reconciling, and
tracking blood products throughout the blood supply chain. The increasing use
of radiofrequency identification (RFID) and needle free devices is expected to
create opportunities for the manufacturers of blood collection products. However,
risk associated with blood transfusions and growing needlestick injuries are the
key factors hampering the growth of the global market.
The key players operating in the global blood collection market are Abbott Laboratories Inc., Becton, Dickinson and Company, Terumo Corporation, Sarstedt AG & Co., Nipro Medical Corporation, Qiagen, Haemonetics Corporation, Greiner Holding AG and F.L. Medical SRL.
No comments:
Post a Comment